Authors


Quentin Van Meter, MD

Latest:

Final Thoughts on Identifying and Managing Patients with T1D

Panelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.


Quinn Everts

Latest:

Mifepristone Future Uncertain, Pushback is United and Swift

The FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.


Marco Meglio

Latest:

Axsome Therapeutics: FDA Accepts NDA Resubmission for AXS-07 for Acute Treatment of Migraine

Based on its acceptance of the resubmission, FDA has assigned a PDUFA action goal date of January 31, 2025 for AXS-07.


Craig Primack, MD

Latest:

Stress Management 2021: The Case for Self-Care in the COVID-19 Era

Obesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.


Rose McGowan

Latest:

Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 Trial

Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.


Lauren Massaro

Latest:

GoodRx, Opill Team Up on OTC Delivery Program for Contraceptive

The new e-commerce partnership expands access to Opill by allowing direct delivery of the contraceptive to consumers' homes without a prescription.


John Parkinson

Latest:

WHO Recommends Flu Vaccine Composition for 2025-26 Northern Hemisphere Season as US HHS Cancels ACIP, VRBAC Meetings

Two official US vaccine planning meetings cancelled in February is an "unprecedented situation," said NFID medical director Robert Hopkins, Jr, MD.


Abha Choudhary, MD

Latest:

Key Insights and Final Thoughts on Screening and Management of T1D

Panelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.


Raj Chovatiya, MD, PhD, MSCI

Latest:

Does it Itch? Is it Painful? Is it Dry? Dermatoses Symptoms Don't Lie

Raj Chovatiya, MD, PhD, MSCI, actually said symptoms "never" lie so, particularly in patients with skin of color, if skin signs aren't clear, ask about the patient's experience.


Mylynda Massart, MD, PhD

Latest:

The Future of Multi-Cancer Early Detection

To close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.



Paul Arnstein, RN, PhD, FAAN

Latest:

Take-home Messages for Acute Pain Management

Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.


R Scott Turner, PhD, MD

Latest:

Patient Selection for Lecanemab to Treat Early Alzheimer Dementia: Details with R Scott Turner, PhD, MD

Dr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.


Maggie L. Shaw

Latest:

New ACP Guidelines on Prevention of Episodic Migraine Cite Lack of Comparative Evidence for Treatments

Pharmacologic treatment to prevent episodic migraine should follow a sequential trial approach that considers medication cost, headache triggers, adherence, and lifestyle interventions.


Lindsay Carr

Latest:

Cannabis Legalization and Prenatal Marijuana Use: Pregnant Women Describe Impact

New research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.


Todd Shryock

Latest:

How do Americans Handle Being Sick?

A recent survey reveals some surprising facts about who handles illness better - men or women.


Editorial Interview

Latest:

Breast Cancer Rehab and Primary Care, with PM&R Specialist Sean Smith, MD

Breast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.


Ryan Flinn

Latest:

Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New Data

After 60 months of treatment, 38% of study participants with severe AD achieved complete remission.


Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Latest:

Vaccination Strategies Practice Pearls And Key Take Aways

Drs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.


Richard Payerchin

Latest:

The Superbug Challenge: Medicine's Essential Fight Against Antimicrobial Resistance

A medical director of antimicrobial stewardship at a large metropolitan health system highlights the dangers of AMR and how she believes the pharmaceutical industry could help.


Gina Battaglia, PhD

Latest:

Expert Panel Offers Guidance on Testing for COVID-19, Influenza, RSV During Respiratory Virus Season 2023-2024

As flu season approaches this year, experts stress that it's not just about influenza anymore; they discuss testing, antiviral treatment, and management of coinfection.


James Hennessey, MD, FACP

Latest:

Clinical Implications of Off Target TSH Levels and Importance of Patient Education in Managing Hypothyroidism

Endocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.


Jeff Gudin, MD

Latest:

Take-home Messages for Acute Pain Management

Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.


Andrew Carroll, MD

Latest:

It's High Time to Normalize Pre-Visit Lab Testing

Research demonstrates that discussing test results face-to-face with patients during office visits is beneficial for patient and clinician, according to family physician Andrew Carroll, MD.


George T Grossberg, MD

Latest:

For Alzheimer Agitation, a Novel, Oral NMDA Inhibitor Could be the Next Targeted Treatment

Geriatric psychiatrist and neurocognitive researcher George Grossberg, MD, highlights the mechanism of action for the new dextromethorphan/bupropion combination.


Giuliana Grossi

Latest:

Racial Disparities Persist in Respiratory Disease Research, Diagnostics: Expert Panel Discussion at 2024 ATS

Pulmonology experts agreed that adopting race-neutral diagnostic and research practices could help mitigate a range of inequities faced by minority populations.


Nima Ahmadi

Latest:

Why is Wound Care Falling to Primary Care?

Overscheduled and undertrained, primary care clinicians shoulder a significant portion of the US wound care burden. Author Nima Ahmadi offers a technology-based solution.


Tori Butur, MSN, APRN, FNP-BC

Latest:

Obesity and the Musculoskeletal System: Age and Impact

Excess weight diminishes the development and function of the musculoskeletal system at any point in the lifespan. An obesity specialist highlights the dangers.


Guillermo E. Umpierrez, MD, CDCES, FACE, MACP

Latest:

Navigating Hypoglycemia Challenges Associated with Dumping Syndrome

The expert panel concludes by examining strategies for managing hypoglycemia challenges related to dumping syndrome, particularly in the context of continuous glucose monitoring use.


David Robertson, MD

Latest:

Final Thoughts on Identifying and Managing Patients with T1D

Panelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.

© 2025 MJH Life Sciences

All rights reserved.